Patent · US Expired

Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B

US5532246A · kind A · utility

26Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 1993
Grant dateJul 2, 1996
Priority date—
Expiry dateAug 9, 2013

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Use of a compound of formula (I) or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for the treatment of hepatitis B is disclosed. ##STR1##

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.